Variation in Presentation, Diagnosis, and Management of Children and Adolescents With ADHD Across European Countries

2015 ◽  
Vol 22 (10) ◽  
pp. 911-923 ◽  
Author(s):  
Juliana Setyawan ◽  
Moshe Fridman ◽  
Regina Grebla ◽  
Valerie Harpin ◽  
Lisa M. Korst ◽  
...  
Keyword(s):  
Treatment Modality ◽  
European Countries ◽  
Diagnostic Approach ◽  
Adhd Symptoms ◽  
Diagnosis And Management ◽  
Treatment Switching ◽  
Diagnostic And Statistical Manual ◽  
The United Kingdom ◽  
Diagnostic Approaches ◽  
Clinical Records

Objective: To characterize differences in presentation, diagnosis, and management of children/adolescents with ADHD in six European countries. Method: Physicians abstracted clinical records for patients aged 6 to 17 years, diagnosed from 2004 to 2007 and treated for ≥2 years. Documentation included impairment due to core ADHD symptoms and additional ADHD symptoms/behaviors at diagnosis, diagnostic approach, and treatment modality. Results: Study included 779 patients treated by 340 physicians. Prevalence of ADHD subtypes (inattention, hyperactivity/impulsivity, or combined) was similar across countries. Mean scores for core and noncore symptom impairment varied and were highest in Italy and the United Kingdom. Variability was noted in diagnostic approach; 95% of physicians in the Netherlands used Diagnostic and Statistical Manual of Mental Disorders (4th edition) criteria versus 10% in Germany. Differences were reported for initial treatment modality, treatment switching, and physician-reported treatment outcomes. Conclusion: European countries varied in diagnostic approaches and practice management of children/adolescents with ADHD.

scholarly journals Host Immune Response and Novel Diagnostic Approach to NTM Infections

2020 ◽  
Vol 21 (12) ◽  
pp. 4351
Author(s):  
Yuko Abe ◽  
Kiyoharu Fukushima ◽  
Yuki Hosono ◽  
Yuki Matsumoto ◽  
Daisuke Motooka ◽  
...  
Keyword(s):  
Immune Response ◽  
Immune Responses ◽  
Humoral Immunity ◽  
Diagnostic Approach ◽  
Post Transplantation ◽  
Diagnosis And Management ◽  
Immunological Responses ◽  
Host Immune Responses ◽  
Diagnostic Approaches ◽  
Proper Diagnosis

The incidence and prevalence of non-tuberculous mycobacteria (NTM) infections are steadily increasing worldwide, partially due to the increased incidence of immunocompromised conditions, such as the post-transplantation state. The importance of proper diagnosis and management of NTM infection has been recently recognized. Host immunological responses play integral roles in vulnerability to NTM infections, and may contribute to the onset of specific types of NTM infection. Furthermore, distinct NTM species are known to affect and attenuate these host immune responses in unique manners. Therefore, host immune responses must be understood with respect to each causative NTM species. Here, we review innate, cellular-mediated, and humoral immunity to NTM and provide perspectives on novel diagnostic approaches regarding each NTM species.

Zmiany dochodowości gospodarstw mlecznych w Polsce i wybranych krajach europejskich należących do Europejskiego Stowarzyszenia Producentów Mleka w latach 2006–2012

2015 ◽  
pp. 97-109
Author(s):  
Sylwia Małażewska ◽  
Edyta Gajos
Keyword(s):  
Milk Production ◽  
Dairy Farms ◽  
European Countries ◽  
Global Markets ◽  
Agricultural Producers ◽  
Significant Deterioration ◽  
Gradual Improvement ◽  
The United Kingdom ◽  
National Market ◽  
The Eu

The aim of the article was to present the changes in the profitability of milk production in farms associated in EDF and situated in Poland and selected European countries in 2006–2012. It was found that after the Polish accession to the EU, the situation has improved for milk producers – economic and production results have risen. In 2008–2009, there was a significant deterioration in the profitability of milk production due to, among others, significant declines in milk prices. Since 2010, gradual improvement of the situation is observed. Similar changes occur in dairy farms in other European countries, such as Germany, France and the United Kingdom. This shows how big the interconnectedness between countries is and that the situation of agricultural producers in Poland does not depend only on the local and national market fluctuations, but primarily on fluctuations in the European and global markets.

scholarly journals COVID-19 in Latin America: a first glance to the mortality

2020 ◽  
pp. 1-3 ◽  
Author(s):  
Nubia Muñoz
Keyword(s):  
Latin America ◽  
Latin American ◽  
Mortality Rates ◽  
European Countries ◽  
Death Rates ◽  
Death Toll ◽  
The United Kingdom ◽  
Health Authorities ◽  
The Us ◽  
Latin American Countries

It is too early to know which will be the final death toll from the Covid-19 or SARS-CoV-2 virus epidemy in Latin America since the epidemy is still active and we will not know when it will end. The curve for new infections and deaths has not reached yet a peak (Figure 1). In addition, we know little about the epidemiology of this new virus. The daily litany of the number of people infected with the number of admissions to hospitals and intensive care units and the number of deaths guides health authorities to plan health services and politicians to gauge the degree of confinement necessary to control the transmission of the virus, but it says little about the magnitude of the problem if we do not relate it to the population at risk. At the end of the pandemic, we will be able to estimate age-standardized death rates for the different countries, but until then the crude death rates will provide a first glance or snapshot of the death toll and impact of the pandemic from March to May 2020. These rates are well below those estimated in other countries in Europe and North America: Belgium (82.6), Spain (58.0), the United Kingdom (57.5), Italy (55.0), France (42.9), Sweden (41.4), and the US (30.7). (Johns Hopkins CSSE, May 30, 2020). However, in the European countries and the US the number of deaths has reached a peak, while this is not the case in Latin American countries. (Figure 1). It should be taken into account that the above rates are crude and therefore, some of the differences could be due to the fact that European countries have a larger proportion of the population over 70 years of age in whom higher mortality rates have been reported.

scholarly journals Analysis on the participation of the main sovereign wealth funds in European listed companies

2019 ◽  
Vol 5 (2) ◽  
pp. 1-13
Author(s):  
L. Gómez-Pavón Durán
Keyword(s):  
Logistic Regression ◽  
United Kingdom ◽  
Home Country ◽  
European Countries ◽  
Company Size ◽  
Economic Sector ◽  
Sovereign Wealth Funds ◽  
The United Kingdom ◽  
Determining Factors ◽  
The One

The aim of this study is to conduct an analysis of the investment made by the fifteen largest sovereign wealth funds on listed European companies. The analysis is divided into two sections: a descriptive one and a statistical one. The methodology used for this purpose consisted of mining data from Orbis database and running a binomial logistic regression. The main results show that, in the first place, the Norwegian fund is the one that invests in a larger amount of companies and European countries. Another significant result indicates that the United Kingdom is the country that receives the most investment. Finally, the results lead also to the conclusion that, concerning investing, sovereign wealth funds are influenced by a set of factors such as company size, profitability, and leverage, whereas the company’s home country and the economic sector it belongs are not determining factors.

scholarly journals A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom

2021 ◽  
Author(s):  
Hélène Bricout ◽  
Rigoine de Fougerolles Thierry ◽  
Joan Puig-Barbera ◽  
Georges Kassianos ◽  
Philippe Vanhems ◽  
...  
Keyword(s):  
United Kingdom ◽  
Medical Information ◽  
Public Awareness ◽  
Data Communication ◽  
European Countries ◽  
World Health ◽  
Influenza Surveillance ◽  
Molecular Testing ◽  
Surveillance Systems ◽  
The United Kingdom

Background: In response to the coronavirus disease (COVID-19) outbreak that unfolded across Europe in 2020, the World Health Organisation called for repurposing existing influenza surveillance systems to monitor COVID-19. This analysis aimed to compare descriptively the extent to which influenza surveillance systems were adapted and enhanced, and how COVID-19 surveillance could ultimately benefit or disrupt routine influenza surveillance. Methods: We used a previously developed framework in France, Germany, Italy, Spain and the United Kingdom to describe COVID-19 surveillance and its impact on influenza surveillance. The framework divides surveillance systems into 7 sub-systems and 20 comparable outcomes of interest, and uses 5 evaluation criteria based on WHO guidance. Information on influenza and COVID-19 surveillance systems were collected from publicly available resources shared by European and national public health agencies. Results: Overall, non-medically attended, virological, primary care and mortality surveillance were adapted in most countries to monitor COVID-19, whilst community, outbreak, and hospital surveillance were reinforced in all countries. Data granularity improved, with more detailed demographic and medical information recorded. A shift to systematic notification for cases and deaths enhanced both geographic and population representativeness whilst the sampling strategy benefited from the roll out of widespread molecular testing. Data communication was greatly enhanced, contributing to improved public awareness. Conclusions: Well-established influenza surveillance systems are a key component of pandemic preparedness and their upgrade allowed European countries to respond to the COVID-19 pandemic. However, uncertainties remain on how both influenza and COVID-19 surveillance can be jointly and durably implemented.

scholarly journals Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008

2008 ◽  
Vol 13 (31) ◽  
Author(s):  
E J Kuijper ◽  
F Barbut ◽  
J S Brazier ◽  
N Kleinkauf ◽  
T Eckmanns ◽  
...  
Keyword(s):  
Clostridium Difficile ◽  
European Countries ◽  
Epidemiological Surveillance ◽  
Resistance Pattern ◽  
Positive Type ◽  
Ribotype 027 ◽  
High Relapse Rate ◽  
The United Kingdom ◽  
Pcr Ribotype 027 ◽  
Highly Virulent

Outbreaks of Clostridium difficile infections (CDI) with increased severity, high relapse rate and significant mortality have been related to the emergence of a new, hypervirulent C. difficile strain in North America and Europe. This emerging strain is referred to as PCR ribotype 027 (Type 027). Since 2005, individual countries have developed surveillance studies about the spread of type 027. C. difficile Type 027 has been reported in 16 European countries. It has been responsible for outbreaks in Belgium, Germany, Finland, France, Ireland, Luxembourg, The Netherlands, Switzerland and the United Kingdom (England, Wales, Northern Ireland and Scotland). It has also been detected in Austria, Denmark, Sweden, Norway, Hungary, Poland and Spain. Three countries experienced imported patients with CDI due to Type 027 who acquired the infection abroad. The antimicrobial resistance pattern is changing, and outbreaks due to clindamycin-resistant ermB positive Type 027 strains have occurred in three European countries. Ongoing epidemiological surveillance of cases of CDI, with periodic characterisation of the strains involved, is required to detect clustering of cases in time and space and to monitor the emergence of new, highly virulent clones.

scholarly journals DIAGNOSIS OF ENDOCRINE DISEASE: Diagnostic approach to TSH-producing pituitary adenoma

2017 ◽  
Vol 177 (4) ◽  
pp. R183-R197 ◽  
Author(s):  
Axel Tjörnstrand ◽  
Helena Filipsson Nyström
Keyword(s):  
Rare Condition ◽  
Diagnostic Approach ◽  
Laboratory Assessment ◽  
Pituitary Mass ◽  
Endocrine Disease ◽  
Clinical Presentations ◽  
Practical Suggestion ◽  
Tsh Secretion ◽  
Diagnostic Approaches ◽  
Inappropriate Tsh Secretion

Thyrotropin (TSH)-secreting adenomas (TSHomas) are the rarest form of pituitary adenomas, and most endocrinologists will see few cases in a lifetime, if any. In most cases, the diagnostic approach is complicated and cases may be referred after being presented as a syndrome of inappropriate TSH secretion or as a pituitary mass. This review aims to cover the past, present and possible future diagnostic approaches to TSHomas, including different clinical presentations, laboratory assessment and imaging advances. The differential diagnoses will be discussed, as well as possible coexisting disorders. By evaluating the existing reports and reviews describing this rare condition, this review aims to present a clinically practical suggestion on the diagnosic workup for TSHomas, Major advances and scientific breakthroughs in the imaging area in recent years, facilitating diagnosis of TSHomas, support the belief that future progress within the imaging field will play an important role in providing methods for a more efficient diagnosis of this rare condition.

The diagnosis and management of insomnia in the United Kingdom Armed Forces

2015 ◽  
Vol 101 (1) ◽  
pp. 80-88
Author(s):  
LD Baker ◽  
RH Coetzee
Keyword(s):  
Primary Care ◽  
United Kingdom ◽  
Armed Forces ◽  
Common Condition ◽  
Diagnosis And Management ◽  
The United Kingdom ◽  
Care Facilities ◽  
Military Populations ◽  
Clinical Considerations

AbstractInsomnia is a common condition among patients presenting to primary care facilities in both civilian and military populations. This article considers the diagnosis, management and clinical considerations of managing this condition, along with the occupational and operational considerations for the United Kingdom Armed Forces.

The Demography of CAPD in Europe

1984 ◽  
Vol 4 (2_suppl) ◽  
pp. 80-84 ◽  
Author(s):  
AJ Wing ◽  
R Moore ◽  
FP Brunner ◽  
C Jacobs ◽  
P Kramer ◽  
...  
Keyword(s):  
Renal Failure ◽  
United Kingdom ◽  
European Countries ◽  
Eastern European ◽  
End Stage Renal Failure ◽  
The United Kingdom ◽  
National Programmes ◽  
Different Populations ◽  
Eastern European Countries ◽  
End Stage

Five per cent of European patients on therapy for end stage renal failure and reported to the EDTA Registry were treated by CAPD on 31st December, 1982. The percentage varied between 12.7% in the United Kingdom to less than 1% in Eastern European countries. In the total area covered by the Registry (population 574 millions) 5.6 patients pmp commenced CAPD during 1982. Commencements reached 18.9 pmp in Switzerland, 17.4 pmp in the United Kingdom and 9.8 pmp in Italy. National programmes of CAPD fulfil different roles in the pattern of RRT and select different populations of patients. Therefore comparisons of the results achieved have not been made.

Sign in / Sign up

Export Citation Format

Share Document